HIV-related costs in public hospital settings

Impact of HAART

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Antiretroviral (AR) therapy is associated with a lower incidence of opportunistic infections and hospitalization, but the cost of AR drugs is high. For publicly funded health care facilities, determining whether there is a total cost benefit in using AR therapy is important to ensure continued funding. In a study of AR therapy at the Veterans Affairs Medical Center in Dallas, we found a steep initial decline in total costs that coincided with the introduction of new regimens, including protease inhibitors and highly active antiretroviral therapy (HAART). As initial therapy on patients began to fail, however, costs increased with the use of more intensive regimens. A similar pattern of initial cost decrease followed by slight increase was found in another study of the publicly funded Parkland HIV/AIDS Clinic. Results still showed that it was more costly to treat patients who did not receive HAART than it was for those who did receive HAART regimens.

Original languageEnglish (US)
JournalInfectious Diseases in Clinical Practice
Volume10
Issue numberSUPPL. 1
StatePublished - 2001
Externally publishedYes

Fingerprint

Public Hospitals
Highly Active Antiretroviral Therapy
HIV
Costs and Cost Analysis
Drug Costs
Health Facilities
Opportunistic Infections
Veterans
Therapeutics
Protease Inhibitors
Cost-Benefit Analysis
Acquired Immunodeficiency Syndrome
Hospitalization
Delivery of Health Care
Incidence

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

HIV-related costs in public hospital settings : Impact of HAART. / Keiser, Philip.

In: Infectious Diseases in Clinical Practice, Vol. 10, No. SUPPL. 1, 2001.

Research output: Contribution to journalArticle

@article{ba600f2951f5441e8c499e24619d6919,
title = "HIV-related costs in public hospital settings: Impact of HAART",
abstract = "Antiretroviral (AR) therapy is associated with a lower incidence of opportunistic infections and hospitalization, but the cost of AR drugs is high. For publicly funded health care facilities, determining whether there is a total cost benefit in using AR therapy is important to ensure continued funding. In a study of AR therapy at the Veterans Affairs Medical Center in Dallas, we found a steep initial decline in total costs that coincided with the introduction of new regimens, including protease inhibitors and highly active antiretroviral therapy (HAART). As initial therapy on patients began to fail, however, costs increased with the use of more intensive regimens. A similar pattern of initial cost decrease followed by slight increase was found in another study of the publicly funded Parkland HIV/AIDS Clinic. Results still showed that it was more costly to treat patients who did not receive HAART than it was for those who did receive HAART regimens.",
author = "Philip Keiser",
year = "2001",
language = "English (US)",
volume = "10",
journal = "Infectious Diseases in Clinical Practice",
issn = "1056-9103",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - HIV-related costs in public hospital settings

T2 - Impact of HAART

AU - Keiser, Philip

PY - 2001

Y1 - 2001

N2 - Antiretroviral (AR) therapy is associated with a lower incidence of opportunistic infections and hospitalization, but the cost of AR drugs is high. For publicly funded health care facilities, determining whether there is a total cost benefit in using AR therapy is important to ensure continued funding. In a study of AR therapy at the Veterans Affairs Medical Center in Dallas, we found a steep initial decline in total costs that coincided with the introduction of new regimens, including protease inhibitors and highly active antiretroviral therapy (HAART). As initial therapy on patients began to fail, however, costs increased with the use of more intensive regimens. A similar pattern of initial cost decrease followed by slight increase was found in another study of the publicly funded Parkland HIV/AIDS Clinic. Results still showed that it was more costly to treat patients who did not receive HAART than it was for those who did receive HAART regimens.

AB - Antiretroviral (AR) therapy is associated with a lower incidence of opportunistic infections and hospitalization, but the cost of AR drugs is high. For publicly funded health care facilities, determining whether there is a total cost benefit in using AR therapy is important to ensure continued funding. In a study of AR therapy at the Veterans Affairs Medical Center in Dallas, we found a steep initial decline in total costs that coincided with the introduction of new regimens, including protease inhibitors and highly active antiretroviral therapy (HAART). As initial therapy on patients began to fail, however, costs increased with the use of more intensive regimens. A similar pattern of initial cost decrease followed by slight increase was found in another study of the publicly funded Parkland HIV/AIDS Clinic. Results still showed that it was more costly to treat patients who did not receive HAART than it was for those who did receive HAART regimens.

UR - http://www.scopus.com/inward/record.url?scp=0034840077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034840077&partnerID=8YFLogxK

M3 - Article

VL - 10

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

SN - 1056-9103

IS - SUPPL. 1

ER -